Krishna Yeshwant

[Krishna Yeshwant @kyeshwant]

@cremieuxrecueil @skathire https://t.co/mV4h4VRp1m

[Krishna Yeshwant @kyeshwant]

@cremieuxrecueil From a 10-page research grant proposal in 2016 to today — a journey ten years in the making. Congrats to @skathire and the Verve team on a decade of remarkable progress. https://t.co/9rpU4idQYT

[Crémieux @cremieuxrecueil]

Eli Lilly has done it.

They've gone and made what seems to be a powerful, permanent gene therapy for LDL cholesterol.

That means they'll be able to effectively prevent most heart disease with a single infusion!

[GV @GVteam]

@EvidenceOpen @kleinerperkins To see how OpenEvidence is truly transforming healthcare, read our blog:
https://t.co/n8ce2PB4I1

[GV @GVteam]

.@EvidenceOpen just closed their $210M Series B and we’re thrilled to co-lead the round alongside @kleinerperkins. OpenEvidence allows clinicians to get immediate evidence-based answers at the point of care and is used today by 40% of doctors in the US. Congrats to founder Daniel Nadler and the team!

[GV @GVteam]

Lenny's Podcast is one of our favorites for actionable startup advice, so it was awesome to have GV's @mmargolis as a guest. Michael breaks down how to quickly zero in on your bullseye customer and value prop — in one day! Have a listen 🎧

[Osmo @Osmo_Labs]

Counterfeiting costs retailers billions every year 💸Osmo’s AI-powered sensors are transforming authentication by detecting real products from fake ones with precision. Be part of the future—join the Osmo community today: https://t.co/17Rb7Cgql3 #DigitalOlfaction #Osmo #ScentTech

[Alex Wiltschko @awiltschko]

Well, we actually did it. We digitized scent. A fresh summer plum was the first fruit and scent to be fully digitized and reprinted with no human intervention. It smells great.

Holy moly, I’m still processing the magnitude of what we’ve done. And yet, it feels like as we cross this finish line we are instantly at a new starting line. I’ll have more to share about what’s in store that we’re building on top of this.

A huge HUGE congrats to the entire team across scientific, engineering, operational, and creative disciplines. It takes a village named Osmo to do this.

I don’t know if this is embarrassing, but I carry the plum scent with me a lot of places and smell it constantly. It makes me smile.

I’m curious, if y’all want to smell it? If we made a limited release fragrance of the first teleported scent and dedicated the proceeds to science, would you want it?

[GV @GVteam]

“Venture at its best is able to support founders in making the impossible possible...That ethos is something that’s in GV’s DNA.”

@FortuneMagazine’s @agarfinks looks inside the first 15 years of GV and our plans for the next 300 — https://t.co/OusOG0iGmb

[Rhys Hughes @hughes_rhys]

Ive had the pleasure of spending time with @awiltschko including touring their NY 🗽 facility and labs.
What the @Osmo_Labs team is building is absolutely mind blowing and the use cases will be many! 🤯
Just as importantly; the culture in the office is awesome and testament to Alex and his teams leadership. SUPER excited about this one! @GVteam

[ACS Division of Medicinal Chemistry @AcsMedi]

Congratulations to the 2024 ACS Division of Medicinal Chemistry #HOF Inductees! This years inductees have a long‐standing record of achievement in medicinal chemistry. We will honor inductees at a reception at the Fall ACS national meeting in Denver and we hope to see you there!

[GV @GVteam]

Welcome to GV, Santa Ana Bio!

We're thrilled to lead Santa Ana Bio's Series B as the company furthers the development of targeted therapies for patients with autoimmune and inflammatory diseases.

Learn more about today's news in @FierceBiotech — https://t.co/o8JYRplEHE

[Krishna Yeshwant @kyeshwant]

Welcome to the team, Elena! We’re excited to work with you. https://t.co/yWGJVBf6UT

[GV @GVteam]

We're excited to announce @elena_sakach as our newest investment partner in SF!

Elena will lead investments across fintech, software, and AI. We’re incredibly excited to see her impact at GV and across the portfolio. Welcome to the team! https://t.co/3jTbsZ6IgI

[Harry Stebbings @HarryStebbings]

I’ve been doing 20VC for 10 years.

There have been good times, there have been bad times.

Through all of them, @Thulme has been there for me.

He is one of the greats, and this show was a result of years in friendship.

My top lessons 👇

[Krishna Yeshwant @kyeshwant]

Proud to get to work with @thulme - Great interview!

[GV @GVteam]

“At GV, anyone can bring forward an idea and explore it.”

GV’s @thulme sat down with @HarryStebbings' @twentyminutevc to talk about building great cultures, advice for founders, and insights from decades in venture — https://t.co/7PWVoOvxg5

[David Schenkein @schenkein]

We are so excited to work with Kevin and his team on a completely novel approach to cancer therapy with the potential to help patients with cancer

[Krishna Yeshwant @kyeshwant]

@mandykakavas @marksy11 @leilei_wuu @schenkein Congrats @marksy11 and team! Very excited!

[Mandy (Kakavas) Stolpa @mandystolpa]

Congratulations to GV EIR @marksy11 on the launch of Delphia Tx! 🎊@leilei_wuu talks with Kevin and @schenkein about flipping the script on cancer care w/ activation lethality: https://t.co/174TTbhPi2

[GV @GVteam]

We're excited to announce @NicoleGaudelli as GV’s newest life sciences entrepreneur in residence! 🎉🧬

As an esteemed scientist and Adenine Base Editing inventor, Nicole will advance next-generation genomic medicines. Learn more in @Forbes ➡️ https://t.co/7NRt2eXmeN

[Krishna Yeshwant @kyeshwant]

We’re incredibly excited to congratulate our longtime friend and colleague Anthony Philippakis as GV’s newest general partner. Congratulations! https://t.co/obwWk0ZlrV

[GV @GVteam]

This week, we were delighted to host GV’s healthcare founder community for breakfast, in partnership with @oakhcft and @hlthevent!

A special thank you to everyone who joined us during @JPMorgan’s #JPM2024.